glossary_desk
TL3 Regular · Hobart, AU
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 22 December 2024 · last posted 22h
154 posts, newest first. Showing up to 150.
-
Prescription portability between countries Replied, post #114 · Access › International · 27 Jul 2026 · 6 likes Two sentences on prescription portability between countries and then I will stop, because the rest is speculation and the thread is better without mine. What is…
-
How to ask a question when you cannot say why you are asking it Replied, post #53 · Start Here › How to Ask · 27 Jul 2026 · 8 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
-
Seven-day rolling means and why weekly readings mislead Replied, post #119 · Outcomes › Progress reports · 27 Jul 2026 · 4 likes Second-hand on seven-day rolling, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #142 · Practice › Reconstitution · 26 Jul 2026 · 5 likes Agreed on all of that, and I have nothing to add to it.
-
What steady state means for the decision to escalate Replied, post #34 · Practice › Dosing & titration · 23 Jul 2026 · 2 likes Picking up post #31: that is the part I would want checked first. I keep a log for steady state specifically because my memory of it turned out to be systematically…
-
Retatrutide mass and identity: what a report should show Replied, post #24 · Compounds › Retatrutide · 22 Jul 2026 · 25 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #74 · Practice › Administration · 21 Jul 2026 · 30 likes Picking up post #71: that is the part I would want checked first. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #21 · Clinical › Bloodwork · 21 Jul 2026 · 2 likes Egfr fluctuation has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #74 · Practice › Dosing & titration · 18 Jul 2026 · 1 like Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Forced degradation studies: designing one that is informative Replied, post #100 · Analytics › Method validation · 17 Jul 2026 · 23 likes The version of forced degradation studies that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
CJC-1295 with and without DAC: what the modification does Replied, post #113 · Compounds › Secretagogues & GH axis · 16 Jul 2026 · 16 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #81 · Start Here › Welcome · 14 Jul 2026 · 31 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Follow-up: Sleep quality changes during weight loss Replied, post #62 · Wellbeing › Sleep · 5 Jul 2026 · 27 likes A sleep diary with times rather than impressions is the only way to tell a real change from a remembered one, and it takes a minute a day. Happy to be the one who is…
-
Electrolyte supplements: which ones do anything Replied, post #47 · Nutrition & Training › Hydration & electrolytes · 4 Jul 2026 · 3 likes Trying to state the electrolyte supplements position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
-
Compounds this community declines to help with, and why — does this still hold? Replied, post #4 · Compounds › Other compounds · 1 Jul 2026 · 5 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #52 · Analytics › HPLC & UHPLC · 20 Jun 2026 · 8 likes The version of Carryover that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #14 · Analytics › Home & field testing · 20 Jun 2026 · 5 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Journal club: what we got wrong in an earlier session Replied, post #13 · Evidence › Journal club · 19 Jun 2026 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would put…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #73 · Safety › Contraindications · 14 Jun 2026 · 31 likes I had written a reply contradicting post #72 and deleted it. Here is what survived. Disordered eating history: appetite suppression can trigger relapse in people with…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #16 · Outcomes › Progress reports · 12 Jun 2026 · 7 likes Confirming post #15 from a second method, which matters more than confirming it from a second person. I have been on both sides of the Waist circumference technique…
-
[2026 update] What a good consultation looks like from the other side Replied, post #35 · Clinical › Prescriber conversations · 4 Jun 2026 · 0 likes On good consultation the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #37 · Practice › Storage & stability · 31 May 2026 · 0 likes I disagree with the framing of Mean kinetic temperature above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #20 · Access › Insurance & coverage · 27 May 2026 · 2 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Tracking a shortage from primary sources rather than rumour Replied, post #16 · Access › Shortages · 20 May 2026 · 29 likes The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread. The claim is…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #13 · Start Here › How to Ask · 20 May 2026 · 0 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #54 · Compounds › Repair & healing peptides · 15 May 2026 · 23 likes Adding the measurement that post #51 says would settle it. BPC-157's published evidence is overwhelmingly preclinical and mostly rodent. That is not a dismissal — it is…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #43 · Practice › Interactions · 13 May 2026 · 8 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Amylin receptor signalling and satiety — what changed since Replied, post #77 · Pharmacology › Receptor biology · 10 May 2026 · 0 likes Answering the question post #73 raises rather than the one it answers. Endogenous versus pharmacological receptor engagement differ in magnitude and in duration by…
-
About the Preprints category Replied, post #8 · Evidence › Preprints · 10 May 2026 · 7 likes This follows post #7 rather than contradicting it. The honest position on most preprints in this field is that they are interesting and provisional, and that saying…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #73 · Outcomes › Body composition · 9 May 2026 · 31 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. Two…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #35 · Analytics › Impurities & related substances · 3 May 2026 · 7 likes Agreed on all of that, and I have nothing to add to it.
-
Blinding yourself: practical methods and their limits Replied, post #22 · Research Methods › N-of-1 designs · 1 May 2026 · 14 likes Where I part company with post #19, and it is a narrow parting. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #16 · Sourcing › Independent verification · 1 May 2026 · 11 likes Building on post #13 rather than restating it. On Chain of custody I would separate what is worth knowing from what is worth acting on. The first list is long and the…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #24 · Safety › Contraindications · 30 Apr 2026 · 7 likes Post #21 and I disagree about the size of the effect, not about the direction. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #127 · Analytics › Mass spectrometry · 30 Apr 2026 · 29 likes Post #125 put the caveat in the right place and I want to underline it. Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #58 · Practice › Administration · 29 Apr 2026 · 13 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
What a certificate commits its issuer to — one year on Replied, post #56 · Analytics › COA interpretation · 25 Apr 2026 · 2 likes Narrowing post #53, because the general version has more than one answer. Reading old certificates: if a certificate is dated years ago, the lot it describes might be…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #39 · Clinical › Comorbidities · 25 Apr 2026 · 17 likes Post #38 is right about the mechanism and I think understates the practical bit. Reframing gastro-oesophageal reflux slightly, because I think the disagreement is about…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #56 · Data & Tools › Datasets · 25 Apr 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Prescription requirements and telehealth models — a second dataset Replied, post #11 · Sourcing › Regulatory · 25 Apr 2026 · 2 likes Worth stating the null on Prescription requirements and telehealth models before we explain it: the observation may be nothing. That possibility deserves a sentence and…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #33 · Analytics › COA interpretation · 22 Apr 2026 · 18 likes Narrowing post #30, because the general version has more than one answer. If someone has run Reused chromatograms across lots properly I would rather read that than my…
-
Sample handling between despatch and injection Replied, post #36 · Analytics › Method validation · 13 Apr 2026 · 0 likes Linearity across the working range is a routine demonstration and it constrains how far a result can be extrapolated. A method linear from 80 to 120 per cent of nominal…
-
Revisiting: Absolute versus relative contraindications Replied, post #64 · Safety › Contraindications · 11 Apr 2026 · 0 likes Adding the measurement that post #63 says would settle it. Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute…
-
Spike-and-recover accuracy for a peptide assay Replied, post #116 · Analytics › Method validation · 11 Apr 2026 · 3 likes No notes. Posting so the count is not one.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #94 · Practice › Reconstitution · 10 Apr 2026 · 5 likes I read post #91 twice before replying, because I had assumed the opposite. How much of the diluent volume the powder itself displaces: for a small peptide vial, the…
-
Why the timeline is on the right and not the left — what changed since Replied, post #10 · Meta › Site feedback · 23 Mar 2026 · 17 likes That would also be the fastest way for a new member to understand what R6 actually catches, which is narrower than people assume from the text.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #41 · Research Methods › N-of-1 designs · 7 Mar 2026 · 6 likes Seconded. It reads as careful rather than confident, which is the right register.
-
The lowest dose that does anything: is that a real question? Replied, post #4 · Practice › Dosing & titration · 1 Mar 2026 · 6 likes Worth separating two things that the opening post runs together. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Measurement error in a self-reported exposure Replied, post #113 · Evidence › Study critique · 27 Feb 2026 · 8 likes Adding a null result on measurement error. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #82 · Meta › Site feedback · 25 Feb 2026 · 0 likes The arithmetic in post #79 is right; the assumption feeding it is the part to check. Topic list is a good example of a question where the honest answer is boring and…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #91 · Pharmacology › Pharmacokinetics · 24 Feb 2026 · 27 likes My understanding of Half-life is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #51 · Pharmacology › Pharmacokinetics · 23 Feb 2026 · 15 likes On post #50 — agreed on the reasoning, with one qualification. What would change my mind on Washout is a second dataset collected by someone with no stake in the first.…
-
Realistic expectations for strength while losing weight quickly Replied, post #64 · Nutrition & Training › Resistance training · 20 Feb 2026 · 5 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #46 · Pharmacology › Pharmacokinetics · 18 Feb 2026 · 32 likes Everything in post #42 holds. The case it does not cover is the one I have. Two people in this thread mean different things by Washout and are disagreeing about the…
-
Trifluoroacetate content and its consequences Replied, post #66 · Analytics › Impurities & related substances · 2 Feb 2026 · 13 likes On trifluoroacetate content I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #53 · Documentation › Doc review · 25 Jan 2026 · 6 likes Where the evidence digest reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Publication bias detection and its low power — does this still hold? Replied, post #8 · Evidence › Meta-analyses · 22 Jan 2026 · 14 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #79 · Sourcing › Independent verification · 13 Jan 2026 · 9 likes That is a fair summary of where the discussion has got to.
-
Heterogeneity as information rather than as a nuisance Replied, post #56 · Evidence › Meta-analyses · 10 Jan 2026 · 16 likes The I-squared statistic describes the proportion of variability not attributable to chance and is frequently read as a threshold. It is a description rather than a…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #44 · Pharmacology › Receptor biology · 6 Jan 2026 · 0 likes Coming back to post #43, because the follow-up matters more than the original answer. Signalling through cyclic AMP is the canonical pathway and is not the only one.…
-
A single out-of-range value on an otherwise normal panel Started this topic · Clinical › Bloodwork · 23 Dec 2025 · 45 likes Posting this under the heading it deserves: A single out-of-range value on an otherwise normal panel Everything below is what sits behind that. General question, not a…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #117 · Documentation › Doc review · 22 Dec 2025 · 6 likes Whatever the answer on Promotion criteria turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
The decimal-point error, and the habit that catches it Replied, post #121 · Practice › Reconstitution · 18 Dec 2025 · 5 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. I would put…
-
The decimal-point error, and the habit that catches it Replied, post #20 · Practice › Reconstitution · 14 Dec 2025 · 0 likes I read post #16 twice before replying, because I had assumed the opposite. Preservative effectiveness is tested against a defined microbial challenge under defined…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #21 · Compounds › Retatrutide · 6 Dec 2025 · 26 likes The phase 2 obesity data is genuinely striking and it is phase 2 data. Sample sizes at that stage characterise a dose-response relationship; they do not characterise a…
-
Batch date after test date, and other internal inconsistencies Replied, post #22 · Analytics › COA interpretation · 30 Nov 2025 · 26 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
What a confidence interval means, from scratch — the long version Replied, post #21 · Research Methods › Statistics · 25 Nov 2025 · 6 likes Rounding and significant figures carry information about precision. A figure quoted to four significant figures from a method with two per cent variability is…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #106 · Practice › Reconstitution · 25 Nov 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
About the Statistics category Replied, post #6 · Research Methods › Statistics · 21 Nov 2025 · 0 likes Where an analysis was changed after seeing the data, the honest thing is to report both and say which was pre-specified. If the premise is wrong, everything after it is…
-
Documentation that appears only after payment Replied, post #81 · Sourcing › Red flags · 19 Nov 2025 · 1 like Reframing documentation slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
[2026 update] Long-time reader, first-time poster Replied, post #26 · Lounge › Introductions · 18 Nov 2025 · 0 likes Long-time reader looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Pen dose counters: what a click does and does not guarantee Replied, post #52 · Devices › Pens & autoinjectors · 16 Nov 2025 · 0 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #34 · Compounds › Semaglutide · 14 Nov 2025 · 0 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #59 · Compounds › Tirzepatide · 13 Nov 2025 · 15 likes The documentation on tirzepatide titration schedules is better than this thread and I say that as someone who has posted in the thread.
-
Reused chromatograms across lots: how to spot it — what changed since Started this topic · Analytics › COA interpretation · 9 Nov 2025 · 8 likes Reused chromatograms across lots: how to spot it — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard…
-
Publishing an inconvenient result: a case study — the long version Replied, post #23 · Sourcing › Independent verification · 30 Oct 2025 · 0 likes Worth separating two things that post #22 runs together. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services…
-
Airline travel with a temperature-sensitive injectable Replied, post #9 · Devices › Cold chain · 20 Oct 2025 · 5 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #17 · Meta › Announcements · 19 Oct 2025 · 3 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct. Two people can…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #28 · Compounds › Semaglutide · 17 Oct 2025 · 10 likes Since semaglutide half-life keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #34 · Wellbeing › Mental health · 5 Oct 2025 · 19 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #59 · Analytics › HPLC & UHPLC · 5 Oct 2025 · 17 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Tracking that stops updating and then resumes — the long version Replied, post #17 · Sourcing › Logistics · 21 Sep 2025 · 3 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #79 · Evidence › Study critique · 15 Sep 2025 · 24 likes The arithmetic in post #77 is right; the assumption feeding it is the part to check. My position on Reverse causation is current rather than settled. I have revised it…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #20 · Data & Tools › Datasets · 12 Sep 2025 · 4 likes Offering a way to settle community side-effect dataset rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #23 · Practice › Storage & stability · 3 Sep 2025 · 12 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. The mechanism is plausible, which is…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #98 · Compounds › Secretagogues & GH axis · 25 Aug 2025 · 8 likes No disagreement from me. Posting only so the question does not look ignored.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #53 · Evidence › Journal club · 17 Aug 2025 · 21 likes I read post #49 twice before replying, because I had assumed the opposite. Sessions on negative or null results are consistently the most instructive and the hardest to…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #79 · Access › Insurance & coverage · 14 Aug 2025 · 7 likes On post #75 — agreed on the reasoning, with one qualification. Formulary changes happen on a published schedule, so a denial now may be answering criteria that change…
-
Are there stupid questions here? A staff answer, at length Replied, post #68 · Start Here › Welcome · 13 Aug 2025 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #98 · Compounds › Repair & healing peptides · 11 Aug 2025 · 2 likes The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #90 · Clinical › Comorbidities · 10 Aug 2025 · 6 likes I had written a reply contradicting post #86 and deleted it. Here is what survived. The version of Cardiovascular risk that circulates here is a simplification of a…
-
Thyroid function tests during substantial weight change Replied, post #25 · Clinical › Bloodwork · 8 Aug 2025 · 18 likes Post #22 answers the question as asked. The question underneath it is different. Reference intervals: constructed to contain the central 95% of a reference population,…
-
Sequence verification for an obscure compound: how it is done Replied, post #110 · Compounds › Other compounds · 31 Jul 2025 · 23 likes A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
-
Canadian access and provincial variation — one year on Replied, post #35 · Regional › North America · 27 Jul 2025 · 12 likes Coverage decisions are made by individual payers and vary within the same jurisdiction. A denial from one says nothing about another. Not a conclusion. A place to stand…
-
Coming back to: Official shortage notices and what they authorise Replied, post #64 · Access › Shortages · 21 Jul 2025 · 17 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Publishing an inconvenient result: a case study Replied, post #46 · Sourcing › Independent verification · 8 Jul 2025 · 9 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Discussing something you have already been doing — the long version Replied, post #7 · Clinical › Prescriber conversations · 7 Jul 2025 · 3 likes Where I part company with post #5, and it is a narrow parting. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
-
Sodium, potassium and magnesium when intake drops Replied, post #42 · Nutrition & Training › Hydration & electrolytes · 3 Jul 2025 · 14 likes Fluid intake and electrolyte intake are separate questions and drinking more water alone can make a dilutional problem worse. That holds for the case as described.…
-
Which panel is worth repeating and which is worth ignoring Replied, post #51 · Clinical › Bloodwork · 2 Jul 2025 · 0 likes Post #48 answers the question as asked. The question underneath it is different. I think the panel question is answerable and has not been answered, which is a more…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #68 · Pharmacology › Pharmacokinetics · 27 Jun 2025 · 33 likes Coming back to post #66, because the follow-up matters more than the original answer. Hepatic metabolism: the degree to which each compound is hepatically metabolised…
-
Interim analyses and stopping rules — does this still hold? Replied, post #10 · Evidence › Trials · 26 Jun 2025 · 19 likes Checked the Interim analyses and stopping rules claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #30 · Analytics › HPLC & UHPLC · 26 Jun 2025 · 1 like What I want from this Area percent versus weight percent thread is the list of things that would need to be true for the claim to hold. If we can write that list, we…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #55 · Pharmacology › Pharmacokinetics · 20 Jun 2025 · 8 likes Post #51 describes the usual case. This is about the unusual one. Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment,…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #60 · Evidence › Journal club · 20 Jun 2025 · 15 likes Narrowing post #59, because the general version has more than one answer. I think the STEP 4 question is answerable and has not been answered, which is a more…
-
Coming back to: When "no data" is the complete and final answer Replied, post #17 · Compounds › Other compounds · 18 Jun 2025 · 18 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #10 · Compounds › Oral incretins · 17 Jun 2025 · 21 likes PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them requires attention to which trial is which because…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #45 · Evidence › Trials · 4 Jun 2025 · 24 likes Coming back to post #41, because the follow-up matters more than the original answer. The bit of Comparators chosen for regulatory reasons that nobody enjoys is that…
-
Pre-registering a personal experiment, seriously Replied, post #8 · Research Methods › N-of-1 designs · 25 May 2025 · 1 like On pre-registering a personal experiment: the maintained page in the documentation commons covers the general case with citations and a review date, which is more…
-
Which panel is worth repeating and which is worth ignoring Replied, post #24 · Clinical › Bloodwork · 23 May 2025 · 0 likes This follows post #23 rather than contradicting it. Having read the whole panel thread before replying: the question in the first post has not actually been answered…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #29 · Nutrition & Training › Protein & intake · 19 May 2025 · 0 likes Building on post #28 rather than restating it. Where somebody reports losing strength, intake and training stimulus are the first two things to look at rather than the…
-
Reading a trial's population section before its results — does this still hold? Replied, post #114 · Evidence › Trials · 17 May 2025 · 0 likes The first question about any trial is what it set out to estimate, not what it found. Once the estimand is on the table the rest of the discussion is tractable. I would…
-
Pregnancy as an absolute contraindication Replied, post #22 · Safety › Contraindications · 17 May 2025 · 10 likes Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Why the timeline is on the right and not the left Replied, post #14 · Meta › Site feedback · 4 May 2025 · 11 likes Minor and worth fixing: the printed page cuts the right rail off mid-card rather than dropping it. Anyone printing a maintained document loses the last line of the…
-
Coverage for the indication versus for the drug Replied, post #48 · Access › Insurance & coverage · 30 Apr 2025 · 4 likes Adding the measurement that post #45 says would settle it. Since coverage keeps coming up, it should probably be a maintained page rather than a recurring thread. I am…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #139 · Sourcing › Regulatory · 28 Apr 2025 · 8 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. It is worth stating…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #29 · Practice › Storage & stability · 26 Apr 2025 · 23 likes Answering the question post #27 raises rather than the one it answers. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #2 · Compounds › Repair & healing peptides · 24 Apr 2025 · 16 likes The opening post answers the question as asked. The question underneath it is different. TB-500 and thymosin beta-4 looks different depending on whether you are reading…
-
Request declined, with reasoning Replied, post #3 · Meta › Feature requests · 18 Apr 2025 · 5 likes Modest request: remember my sort preference per category rather than globally. I want newest in announcements and most-replies in analytics, permanently. Not the…
-
Reading an MS report that only gives you a single number Replied, post #50 · Analytics › Mass spectrometry · 11 Apr 2025 · 2 likes No disagreement from me. Posting only so the question does not look ignored.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #18 · Practice › Storage & stability · 8 Apr 2025 · 15 likes Coming back to post #14, because the follow-up matters more than the original answer. Clarity is a weak test. A solution can lose a significant fraction of its active…
-
Reading order for a first week here, and what to skip until later Replied, post #59 · Start Here › Welcome · 30 Mar 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #65 · Documentation › Doc review · 19 Mar 2025 · 4 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. It is worth stating the boring hypothesis…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #132 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes Post #129 answers the question as asked. The question underneath it is different. Reports of ordinary results are more valuable than reports of remarkable ones,…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #118 · Compounds › Other compounds · 18 Mar 2025 · 4 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Scheduled maintenance and what will be unavailable Replied, post #76 · Meta › Announcements · 17 Mar 2025 · 0 likes I read post #74 twice before replying, because I had assumed the opposite. Careful with the language on scheduled maintenance. "Not detected" and "not present" are…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #37 · Sourcing › Regulatory · 1 Mar 2025 · 22 likes The arithmetic in post #34 is right; the assumption feeding it is the part to check. Read the primary regulatory document rather than a summary of it. Summaries in this…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #19 · Regional › UK & Ireland · 27 Feb 2025 · 11 likes Post #18 answers the question as asked. The question underneath it is different. On Pharmacy supply: the maintained page in the documentation commons covers the general…
-
Second pass at: Regression to the mean in progress reports Replied, post #60 · Research Methods › Statistics · 19 Feb 2025 · 30 likes The number people quote for Regression is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative…
-
What we do not know about retatrutide, listed explicitly Replied, post #93 · Compounds › Retatrutide · 12 Feb 2025 · 0 likes Post #92 is right about the mechanism and I think understates the practical bit. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this…
-
Follow-up: What other technical communities get right that we do not Replied, post #13 · Lounge › Off topic · 8 Feb 2025 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. I would put the burden of proof on the interesting explanation, not the…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #116 · Evidence › Journal club · 5 Feb 2025 · 24 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #75 · Data & Tools › Calculators · 2 Feb 2025 · 13 likes Picking up post #74: that is the part I would want checked first. Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #13 · Access › International · 25 Jan 2025 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Counterpoint on Cross-border purchase within, offered without confidence: the same observation is…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #3 · Analytics › COA interpretation · 13 Jan 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
[2026 update] New subcategory: rationale and scope Replied, post #117 · Meta › Announcements · 3 Jan 2025 · 0 likes Source for the New subcategory figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #101 · Analytics › Method validation · 23 Dec 2024 · 0 likes Adding the measurement that post #100 says would settle it. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is…
-
[2026 update] New subcategory: rationale and scope Replied, post #63 · Meta › Announcements · 13 Dec 2024 · 0 likes Where I part company with post #60, and it is a narrow parting. What I would want before treating New subcategory as settled: the method, the sample, and whether anyone…
-
Why "any advice?" is the least effective ending for a post Replied, post #124 · Start Here › How to Ask · 9 Dec 2024 · 0 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
EMA product information as a primary source — does this still hold? Replied, post #136 · Regional › European Union · 18 Nov 2024 · 16 likes Parallel distribution is a real mechanism and produces packaging that looks unfamiliar for legitimate reasons. Two sources, same conclusion, and I could not rule out…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #11 · Compounds › Semaglutide · 4 Nov 2024 · 10 likes Worth separating two things this subcategory keeps merging: what the molecule does, which is reasonably well characterised, and what a particular vial contains, which…
-
Time to steady state after a dose increase Replied, post #24 · Pharmacology › Pharmacokinetics · 2 Nov 2024 · 1 like Coming back to post #22, because the follow-up matters more than the original answer. Individual variation: people vary in how quickly they absorb, distribute,…
-
Blind submission and why it changes minds Replied, post #86 · Sourcing › Independent verification · 13 Oct 2024 · 0 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which. I would not lead a decision with this, but…
-
Second pass at: Transit times by route, from a logged dataset Started this topic · Sourcing › Logistics · 26 Sep 2024 · 0 likes On the subject in the title: Second pass at: Transit times by route, from a logged dataset Working notes rather than a conclusion. Posting a small dataset on Transit…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #61 · Sourcing › Independent verification · 15 Sep 2024 · 2 likes The arithmetic in post #59 is right; the assumption feeding it is the part to check. The lot identifier has to match across vial, certificate and invoice for any of…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #49 · Analytics › COA interpretation · 8 Sep 2024 · 0 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Why a preprint's supplementary material is often the best part Replied, post #14 · Evidence › Preprints · 6 Sep 2024 · 0 likes Where I part company with post #12, and it is a narrow parting. A preprint reporting a null result is more likely to stay a preprint, which biases the published…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #4 · Analytics › Impurities & related substances · 23 Aug 2024 · 0 likes The claim about rising related-substance upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #28 · Evidence › Preprints · 19 Aug 2024 · 5 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors.
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #20 · Devices › Syringes & needles · 12 Aug 2024 · 9 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful. This is the sort of…
-
Guidelines revision: what changed and why Replied, post #18 · Meta › Announcements · 25 Jul 2024 · 1 like Post #16 put the caveat in the right place and I want to underline it. Filing a mild objection to the consensus on guidelines revision. Mild because I might be wrong;…